Pfizer Inc.'s Wyeth Defeats Australian Generic Challenge Against Antidepressant Effexor Patent

November 9, 2010 |

1 min read

Bloomberg -- Wyeth, a unit of Pfizer Inc., beat back a challenge from generic drug makers against the patent on the extended-release form of its antidepressant Effexor in Australia.

Legal Asia Australia

Pfizer

MORE ON THIS TOPIC

Business negotiation and cooperation vector concept. Symbol of a deal, handshake, success. Minimal design eps10 illustration.

Weight loss

GSK goes beyond weight-loss with $1B buyout of Chinese siRNA specialist

May 7, 2026

·

2 min read

·

Tristan Manalac

Recovering losses, effective economic measures to help alleviate inflation or economic crisis resulting in the collapse of the business economy or stock market, helping hands to catch gold coins rolling down a tilted cliff

Patents

Pfizer settles with generic drugmakers to protect blockbuster drug until 2031

April 29, 2026

·

2 min read

·

Nick Paul Taylor

man pulling each of the opposite ends of a rope in black and white, on a blue background with some blank space on top

Pancreatic cancer

Revolution levels legal threat on Erasca as pancreatic cancer rivalry heats up

April 28, 2026

·

3 min read

·

Tristan Manalac

Stack of coins balancing on seesaw over a bottle of pills.

Drug pricing

Regeneron finally joins Trump’s drug pricing push while notching landmark approval

April 24, 2026

·

2 min read

·

Tristan Manalac